Web Results

Poractant alfa

en.wikipedia.org/wiki/Poractant_alfa

Poractant alfa is a pulmonary surfactant sold under the brand name Curosurf by Chiesi Farmaceutici. Poractant alfa is an extract of natural porcine lung ...

Curosurf (Poractant Alfa) Drug Information: Description, User ...

www.rxlist.com/curosurf-drug.htm

Mar 7, 2016 ... CUROSURF (poractant alfa) is a sterile, non-pyrogenic pulmonary surfactant intended for intratracheal use only. CUROSURF is an extract of ...

Poractant Alfa Information from Drugs.com

www.drugs.com/drp/poractant-alfa.html

CUROSURF (poractant alfa) Intratracheal Suspension is a sterile, non-pyrogenic pulmonary surfactant intended for intratracheal use only. It is an extract of ...

Poractant Alfa (Professional Patient Advice) - Drugs.com

www.drugs.com/ppa/poractant-alfa.html

Professional guide for Poractant Alfa. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.

A randomized, multicenter masked comparison trial of poractant alfa ...

www.ncbi.nlm.nih.gov/pubmed/15085492

A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in ...

DailyMed - CUROSURF- poractant alfa suspension

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99bef307-00bd-4379-9f45-ede1380e74d4

These highlights do not include all the information needed to use CUROSURF® safely and effectively. See full prescribing information for CUROSURF.

Curosurf - Summary of Product Characteristics (SPC) - (eMC)

www.medicines.org.uk/emc/medicine/21421

Jul 31, 2015 ... One 1.5 ml vial contains 120mg of phospholipid fraction from porcine lung ( poractant alfa). One 3.0ml vial contains 240mg of phospholipid ...

Curosurf (poractant alfa) dose, indications, adverse effects ...

www.pdr.net/drug-summary/Curosurf-poractant-alfa-1308

Rescue Treatment in Premature Infants: Reduces mortality and pneumothoraces associated w/ respiratory distress syndrome. Initial: 2.5mL/kg birth weight, ...

CUROSURF® (poractant alfa) USER'S GUIDE - Chiesi USA

chiesiusa.com/wp-content/uploads/Curosurf_Users_Guide.pdf

CUROSURF® (poractant alfa) Intratracheal Suspension is available in sterile, ready-to-use rubber-stoppered clear glass vials containing 1.5 mL [120 mg ...

Drug Safety Labeling Changes > Curosurf (poractant alfa ... - FDA

www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm123114.htm

Jun 19, 2009 ... Curosurf (poractant alfa) Intratracheal Suspension September 2008. Detailed View: Safety Labeling Changes Approved By FDA Center for ...

More Info

CUROSURF® (poractant alfa) | Official Website

curosurf.com

Download resources and see CUROSURF® (poractant alfa) benefits & risks, administration, and pharmacy considerations.

Curosurf (poractant alfa) dosing, indications, interactions, adverse ...

reference.medscape.com

Medscape - Indication-specific dosing for Curosurf (poractant alfa), frequency- based adverse effects, comprehensive interactions, contraindications, pregnancy  ...

Poractant Alfa Monograph for Professionals - Drugs.com

www.drugs.com

Poractant Alfa reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI).